Ramargon 30mg Tablets 20s

What it is used for: Depression.

Indications as listed by the manufacturer: Treatment of episodes of major depression in adults.

How it works: Mirtazapine is a centrally active presynaptic a2 -antagonist, which increases central noradrenergic and serotonergic neurotransmission. The enhancement of serotonergic neurotransmission is specifically mediated via 5-HT1 receptors, because 5-HT2 and 5-HT3 receptors are blocked by Mirtazapine. The histamine H1-antagonistic activity of Mirtazapine is associated with its sedative properties.

Active ingredient: Mirtazapine.

Reported side effects: Bone marrow depression (granulocytope-nia, agranulo-cytosis, aplastic anaemia, thrombo-cytopenia) , Eosinophilia , Weight increased , Increase in appetite Abnormal dreams , Confusion , Anxiety , Insomnia , Nightmares , Mania , Agitation , Hallucinations , Psychomotor restlessness (incl. akathisia, hyperkinesia) , Aggression , Suicidal ideation , Suicidal behaviour , Somnolence Sedation , Headache , Lethargy , Dizziness , Tremor , Paraesthesia , Restless legs, Syncope, Myoclonus , Convulsions (insults) , Serotonin syndrome , Oral paresthaesia , Dysarthria.

Known drug interactions: MAO inhibitors , SSRIs , benzodiazepines and other sedatives (notably most antipsychotics, histamine H1 antagonists, opioids , alcohol.

Adults : Initial starting dose is 15mg once daily at night. Titrate according to response , usually 15-45mg as a single dose at night or in two equally divided doses morning and night. Withdraw gradually when symptoms free 4-6 months. Children : Not recommended. OR As directed by your physician .

Active ingredient: Mirtazapine. Labelled strength: 30mg.

Store this medicine at room temperature, away from direct light and heat.

Manufactured by Ramargon Pharma (Pvt) Ltd.. Country of origin: United Arab Emirates.